PL2958935T3 - Szczepionka - Google Patents

Szczepionka

Info

Publication number
PL2958935T3
PL2958935T3 PL14711297T PL14711297T PL2958935T3 PL 2958935 T3 PL2958935 T3 PL 2958935T3 PL 14711297 T PL14711297 T PL 14711297T PL 14711297 T PL14711297 T PL 14711297T PL 2958935 T3 PL2958935 T3 PL 2958935T3
Authority
PL
Poland
Prior art keywords
vaccine
Prior art date
Application number
PL14711297T
Other languages
English (en)
Inventor
Pål PUNTERVOLL
Halvor Sommerfelt
John Clements
James P. Nataro
Weiping Zhang
Arne M. Taxt
Original Assignee
Bergen Teknologioverføring As
The Administrators Of The Tulane Educational Fund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bergen Teknologioverføring As, The Administrators Of The Tulane Educational Fund filed Critical Bergen Teknologioverføring As
Publication of PL2958935T3 publication Critical patent/PL2958935T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL14711297T 2013-02-20 2014-02-20 Szczepionka PL2958935T3 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201361850636P 2013-02-20 2013-02-20
US201361767161P 2013-02-20 2013-02-20
US201361766958P 2013-02-20 2013-02-20
US201361886242P 2013-10-03 2013-10-03
PCT/IB2014/000267 WO2014128555A2 (en) 2013-02-20 2014-02-20 Vaccine
EP14711297.3A EP2958935B1 (en) 2013-02-20 2014-02-20 Vaccine

Publications (1)

Publication Number Publication Date
PL2958935T3 true PL2958935T3 (pl) 2020-03-31

Family

ID=50336353

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14711297T PL2958935T3 (pl) 2013-02-20 2014-02-20 Szczepionka

Country Status (7)

Country Link
US (1) US10166279B2 (pl)
EP (1) EP2958935B1 (pl)
CN (1) CN105658661B (pl)
DK (1) DK2958935T3 (pl)
ES (1) ES2743431T3 (pl)
PL (1) PL2958935T3 (pl)
WO (1) WO2014128555A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014008406A2 (en) 2012-07-05 2014-01-09 Children's Medical Center Corporation The bacterial biofilm matrix as a platform for protein delivery
US11071779B2 (en) 2016-06-17 2021-07-27 Children's Medical Center Corporation Biofilm matrix-boosted vaccine
CN106442988B (zh) * 2016-10-08 2018-03-20 扬州大学 产肠毒素大肠杆菌etec f4菌毛直接受体蛋白猪氨肽酶n功能结合域
EP3841111A1 (en) * 2018-08-24 2021-06-30 Vestlandets Innovasjonsselskap AS Heat-stable enterotoxins mutants as antidiarrheal vaccine antigens

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987237A (en) 1983-08-26 1991-01-22 Ribi Immunochem Research, Inc. Derivatives of monophosphoryl lipid A
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
GB9717652D0 (en) 1997-08-20 1997-10-22 Nycomed Imaging As Method
US7772188B2 (en) * 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20120064114A1 (en) 2008-10-21 2012-03-15 Emergent Product Development United Kingdom Use of e. coli surface antigen 3 sequences for the export of heterologous antigens

Also Published As

Publication number Publication date
ES2743431T3 (es) 2020-02-19
CN105658661A (zh) 2016-06-08
HK1217206A1 (en) 2016-12-30
US20160220654A1 (en) 2016-08-04
EP2958935A2 (en) 2015-12-30
CN105658661B (zh) 2020-07-24
EP2958935B1 (en) 2019-07-03
WO2014128555A3 (en) 2015-02-26
US10166279B2 (en) 2019-01-01
WO2014128555A2 (en) 2014-08-28
DK2958935T3 (da) 2019-09-16

Similar Documents

Publication Publication Date Title
IL276210A (en) MERS-COV vaccine
IL279395A (en) A vaccine
DK3088517T3 (en) Humant anti-il-33-neutraliserende monoklonalt antistof
DK3077519T3 (en) Cmv-vacciner
ZA201508642B (en) Malaria vaccine
GB201315946D0 (en) Oncology vaccine
GB201301085D0 (en) Glycoconjugate Vaccine
DK3056208T3 (en) Immunpotentiator
AU353575S (en) Stamphousing
PL2958935T3 (pl) Szczepionka
GB201417087D0 (en) No detials
DK2979701T3 (en) Antitumormiddel indbefattende irinotecanhydrochloridhydrat
PL2991675T3 (pl) Szczepionka Campylobacter
GB201320646D0 (en) Vaccine
GB201315556D0 (en) Vaccine
DK2989854T3 (en) Strømstyret opvarmningssystem
AU4899P (en) Herbie53 Iresine herbstii
AU4953P (en) Flogazora Gazania rigens
AU4977P (en) Harrosy Gaura lindheimeri
GB201421602D0 (en) Zielfernrohr
GB201310280D0 (en) Odontalgic preparation
AU353328S (en) Kettlebell
AU353327S (en) Kettlebell
AU353325S (en) Kettlebell
AU353326S (en) Kettlebell